Director/PDMR Shareholding

Summary by AI BETAClose X

On September 14, 2025, conditional nil-cost options granted in 2022 under the Genus 2019 Performance Share Plan and Deferred Share Bonus Plan vested, leading members of the Genus Executive Leadership Team to sell ordinary shares between September 15 and 16 to cover tax liabilities. Angelle Rosata exercised 5,760 nil-cost options and sold 2,308 shares at 2,545p, and also exercised 419 nil-cost options and sold 168 shares at 2,545p. Matt Culbertson exercised 1,637 and 3,961 options, selling 477 and 1,154 shares respectively at 2,577p. Elena Rice exercised 6,376 options and sold 2,727 shares at 2,555p, while Jerry Thompson exercised 6,254 options and sold 2,993 shares at 2,567p. Additionally, Culbertson and Birri sold shares from the release of conditional share awards under the PSP, with Culbertson selling 1,007 and 167 shares and Birri selling 499 and 124 shares, all at 2,562p. The proportion of awards to which performance conditions applied would vest at 20% of the original grant.

Disclaimer*

Companies

Genus (GNS)
UK 100

Latest directors dealings